Uncategorized
09/12/2023
Virginia Coordinated Clinical Research Network Launched to Focus on Clinical Trial Research, Developing Medical Treatments, Scientific Advancements, and Real-World Applications
From the development of new medicines and cancer treatments to gene therapy and advances in scientific understanding of serious conditions such as Alzheimer’s disease, clinical research is helping drive the future of medical innovation and patient care. To further support that work, a coalition of health care systems, institutions of higher education, and other organizations …
06/21/2023
Children’s National Hospital Receives $96 Million Investment for Rare Pediatric Brain Tumor Research & Care
Children’s National Hospital announced a $96 million investment from an anonymous donor family that strengthens its globally recognized leadership to transform rare childhood brain tumor research and care. It is one of the largest donations in the hospital’s history. It allows Children’s National to recruit more top talent and advance the most promising research for …
06/09/2023
Apply Now: 📣 BLUE KNIGHT ™️ Resident QuickFire Challenge: Accelerating Project NextGen
Johnson & Johnson Innovation, together with the Biomedical Advanced Research and Development Authority (BARDA), is proud to launch the BLUE KNIGHT™ Resident QuickFire Challenge: Accelerating Project NextGen. Current and alumni Blue Knight residents and their collaborators are invited to submit promising potential pre-clinical or clinical solutions for the opportunity to receive award funding from a …
05/31/2023
Apply Now: BLUE KNIGHT™ QuickPitch: Activating for the Future
Recent global disease outbreaks have had devastating impacts, triggering a renewed emphasis on preparation for potential known and unknown health threats. By proactively enhancing preparedness against emerging pathogens, we aim to minimize the scale of future outbreaks, protect vulnerable populations, and ultimately safeguard our health security. To that end, Johnson & Johnson Innovation, together with …
01/20/2023
$100M donor gift to launch U.Va. biotech institute
Charlottesville, VA, /Virginia Business/ – The University of Virginia will build a biotechnology institute funded with a $100 million donation from Charlottesville investor Paul Manning and his wife, Diane, the university announced Friday. Along with the Mannings’ gift, U.Va. will contribute $150 million, and the state has allocated $50 million in initial investments for the institute …
06/26/2022
USA FDA Grants Fast Track Designation to ReAlta Life Sciences’ Lead Compound RLS-0071
ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE). RLS-0071 is the Company’s lead dual …